Name:	O
___.	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
Dilaudid	O
Attending:	O
___	O
Chief	O
Complaint:	O
High	O
ileostomy	O
output,	O
dizziness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Percutanous	O
___	O
liver	O
biopsy	O
___	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
female	O
with	O
a	O
history	O
of	O
ulcerative	O
colitis	O
s/p	O
proctocolectomy	O
then	O
completion	O
proctectomy	O
with	O
end-ileostomy	O
and	O
hx	O
of	O
SBOs	O
who	O
presents	O
complaining	O
of	O
1	O
week	O
of	O
diarrhea	O
and	O
dizziness.	O
The	O
patient	O
was	O
recently	O
admitted	O
to	O
___	O
and	O
was	O
discharged	O
two	O
days	O
ago	O
with	O
the	O
same	O
problem	O
of	O
orthostatic	O
hypotension	O
and	O
dizziness.	O
She	O
came	O
in	O
with	O
dizziness	O
and	O
diarrhea	O
and	O
was	O
discharged	O
after	O
receiving	O
IVF.	O
However,	O
she	O
went	O
home	O
and	O
did	O
not	O
feel	O
much	O
better.	O
She	O
then	O
called	O
her	O
GI	O
doctor	O
Dr.	O
___	O
recommended	O
that	O
she	O
come	O
in	O
for	O
further	O
evaluation.	O
She	O
has	O
had	O
high	O
stool	O
output	O
through	O
her	O
ileostomy	O
and	O
has	O
to	O
empty	O
her	O
bag	O
at	O
least	O
___	O
times	O
a	O
day	O
and	O
it	O
is	O
entirely	O
watery	O
diarrhea.	O
She	O
has	O
been	O
tolerating	O
po	O
but	O
is	O
unable	O
to	O
keep	O
up	O
with	O
her	O
watery	O
output.	O
Her	O
dizziness	O
is	O
more	O
lightheadedness.	O
She	O
denies	O
any	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
bloody	B-Lower_gastrointestinal_haemorrhage
BM/melena.	B-Lower_gastrointestinal_haemorrhage
She	O
has	O
been	O
taking	O
Lomotil	O
as	O
well	O
as	O
Imodium	O
for	O
her	O
diarrhea.	O
In	O
the	O
ED	O
today,	O
she	O
states	O
her	O
dizziness	O
has	O
resolved.	O
However,	O
her	O
GI	O
doctor,	O
___	O
her	O
to	O
be	O
admitted	O
for	O
further	O
observation	O
and	O
follow	O
up	O
of	O
stool	O
cultures	O
including	O
c.	O
diff,	O
ova/parasites,	O
and	O
cultures.	O
She	O
denies	O
any	O
headache,	O
vision	O
changes,	O
fever,	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
urinary	O
symptoms,	O
weakness	O
numbness	O
or	O
tingling.	O
In	O
the	O
ED:	O
Initial	O
vital	O
signs	O
were	O
notable	O
for:	O
97.7	O
80	O
139/93	O
18	O
98%	O
RA	O
Exam	O
notable	O
for:	O
___	O
systolic	O
murmur	O
Abdomen	O
soft	O
nontender	O
Soft	O
green	O
stool	O
in	O
ileostomy	O
bag	O
Labs	O
were	O
notable	O
for:	O
133|	O
97	O
|	O
8	O
------------	O
<	O
78	O
4.1|	O
27	O
|	O
0.7	O
Studies	O
performed	O
include:	O
None.	O
Patient	O
was	O
given:	O
IVF	O
Consults:	O
GI	O
consult	O
was	O
requested	O
Vitals	O
on	O
transfer:	O
98	O
85	O
116/85	O
17	O
98%	O
RA	O
Past	O
Medical	O
History:	O
PMH:	O
Ulcerative	O
colitis,	O
rheumatoid	O
arthritis,	O
asthma,	O
restless	O
leg	O
syndrome,	O
mild	O
ADD/anxiety,	O
hypothyroidism	O
PSH:	O
open	O
appendectomy,	O
tonsillectomy,	O
total	O
abdominal	O
hysterectomy,	O
b/l	O
thumb	O
joing	O
replacements,	O
R	O
knee	O
replacement,	O
proctocolectomy	O
with	O
end	O
ileostomy	O
___,	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Notable	O
for	O
inflammatory	O
Disease,	O
Colon	O
Cancer.	O
Cancer	O
(other)	O
-	O
mother	O
had	O
lung	O
cancer	O
Brother	O
with	O
atrial	O
fibrillation	O
Physical	O
Exam:	O
Admission	O
Physical	O
Exam	O
==================	O
VITALS:	O
98.2	O
PO	O
132	O
/	O
79	O
R	O
Sitting	O
91	O
18	O
95	O
Ra	O
GENERAL:	O
Alert	O
and	O
interactive.	O
In	O
no	O
acute	O
distress.	O
HEENT:	O
NCAT.	O
PERRL,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
NECK:	O
Thyroid	O
is	O
normal	O
in	O
size	O
and	O
texture,	O
no	O
nodules.	O
No	O
cervical	O
lymphadenopathy.	O
No	O
JVD.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
___	O
harsh	O
systolic	O
murmur	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
No	O
increased	O
work	O
of	O
breathing.	O
ABDOMEN:	O
Normal	O
bowels	O
sounds,	O
non	O
distended,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
No	O
organomegaly.	O
Ileostomy	O
with	O
green-brown	O
watery	O
output	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis,	O
or	O
edema.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
SKIN:	O
Warm.	O
Cap	O
refill	O
<2s.	O
No	O
rash.	O
NEUROLOGIC:	O
CN2-12	O
intact.	O
___	O
strength	O
throughout.	O
Normal	O
sensation.	O
Gait	O
is	O
normal.	O
AOx3.	B-Delirium
========================	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
Tmax	O
97.9	O
Tc	O
97.7	O
HR	O
66	O
BP	O
118/17	O
RR	O
18	O
SpO2	O
95%	O
RA	O
GENERAL:	O
Alert	O
and	O
interactive.	O
Lying	O
in	O
bed	O
and	O
conversant	O
but	O
uncomfortable.	O
HEENT:	O
PERRL,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
___	O
cresc-decresc	O
systolic	O
murmur	O
radiating	O
to	O
the	O
carotids.	O
LUNGS:	O
Lung	O
CTAB.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
Patient	O
noted	O
have	O
pain	O
on	O
deep	O
inspiration.	O
ABDOMEN:	O
Non	O
distended,	O
soft	O
abdomen,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
Ostomy	O
in	O
LLQ	O
pink,	O
mildly	O
protruded.	O
Ostomy	O
bag	O
recently	O
emptied	O
with	O
watery	O
green	O
stool.	O
EXTREMITIES:	O
Warm	O
and	O
well	O
perfused	O
bilaterally.	O
SKIN:	O
Warm,	O
no	O
rashes	O
observed	O
NEUROLOGIC:	O
Alert,	O
speech	O
fluent.	O
CN	O
II-XII	O
grossly	O
intact	O
Pertinent	O
Results:	O
LABORATORY	O
STUDIES	O
==================	O
___	O
06:05AM	O
BLOOD	O
WBC-6.8	O
RBC-3.10*	O
Hgb-9.7*	O
Hct-30.1*	O
MCV-97	O
MCH-31.3	O
MCHC-32.2	O
RDW-13.1	O
RDWSD-46.3	O
Plt	O
___	O
___	O
01:00PM	O
BLOOD	O
WBC-7.1	O
RBC-3.76*	O
Hgb-11.5	O
Hct-36.7	O
MCV-98	O
MCH-30.6	O
MCHC-31.3*	O
RDW-13.4	O
RDWSD-48.8*	O
Plt	O
___	O
___	O
01:00PM	O
BLOOD	O
Neuts-75.2*	O
Lymphs-9.7*	O
Monos-12.1	O
Eos-2.0	O
Baso-0.4	O
Im	O
___	O
AbsNeut-5.37	O
AbsLymp-0.69*	O
AbsMono-0.86*	O
AbsEos-0.14	O
AbsBaso-0.03	O
___	O
06:05AM	O
BLOOD	O
Glucose-75	O
UreaN-11	O
Creat-0.7	O
Na-133*	O
K-4.7	O
Cl-98	O
HCO3-26	O
AnGap-9*	O
___	O
01:00PM	O
BLOOD	O
Glucose-78	O
UreaN-8	O
Creat-0.7	O
Na-133*	O
K-4.1	O
Cl-97	O
HCO3-27	O
AnGap-9*	O
___	O
05:47AM	O
BLOOD	O
ALT-120*	O
AST-89*	O
AlkPhos-144*	O
TotBili-0.5	O
___	O
01:00PM	O
BLOOD	O
ALT-230*	O
AST-221*	O
AlkPhos-218*	O
TotBili-0.5	O
___	O
01:17PM	O
BLOOD	O
25VitD-23*	O
___	O
06:13AM	O
BLOOD	O
HIV	O
Ab-NEG	O
___	O
05:50AM	O
BLOOD	O
PEP-NO	O
SPECIFI	O
___	O
08:33AM	O
BLOOD	O
IgG-897	O
IgA-237	O
IgM-21*	O
___	O
06:49AM	O
BLOOD	O
IgM	O
HAV-NEG	O
___	O
06:49AM	O
BLOOD	O
CRP-0.9	O
IMAGING	O
=======	O
MRCP	O
(___):	O
1.	O
Moderately	O
motion	O
limited	O
study.	O
Allowing	O
for	O
this,	O
no	O
evidence	O
of	O
acute	O
process	O
in	O
the	O
abdomen.	O
No	O
biliary	O
ductal	O
dilatation	O
or	O
abnormal	O
peribiliary	O
enhancement.	O
2.	O
Parastomal	O
hernia	O
containing	O
nonobstructed	O
loops	O
of	O
small	O
bowel.	O
TTE	O
(___):	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
moderately	O
increased.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
normal	O
regional	O
and	O
global	O
left	O
ventricular	O
systolic	O
function.	O
There	O
is	O
no	O
left	O
ventricular	O
outflow	O
tract	O
gradient	O
at	O
rest	O
or	O
with	O
Valsalva.	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
normal	O
free	O
wall	O
motion.	O
The	O
aortic	O
sinus	O
is	O
mildly	O
dilated	O
with	O
mildly	O
dilated	O
ascending	O
aorta.	O
The	O
aortic	O
arch	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
moderately	O
thickened.	O
There	O
is	O
moderate	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
1.0-1.5	O
cm2).	O
There	O
is	O
mild	O
to	O
moderate	O
[___]	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
severe	O
mitral	O
annular	O
calcification.	O
There	O
is	O
minimal	O
functional	O
mitral	O
stenosis	O
from	O
the	O
prominent	O
mitral	O
annular	O
calcification.	O
There	O
is	O
moderate	O
[2+]	O
mitral	O
regurgitation.	O
Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
could	O
be	O
UNDERestimated.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
physiologic	O
tricuspid	O
regurgitation.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
trivial	O
pericardial	O
effusion.	O
IMPRESSION:	O
Moderate	O
aortic	O
valve	O
stenosis.	O
Mild-moderate	O
aortic	O
regurgitation.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
biventricular	O
systolic	O
function.	O
Moderate	O
mitral	O
regurgitation.	O
MInimal	O
functional	O
mitral	O
stenosis.	O
Mildly	O
dilated	O
thoracic	O
aorta.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
Thoracic/Lumbar	O
Spine	O
Radiographs	O
(___):	O
Thoracic	O
spine:	O
There	O
is	O
diffuse	O
osteopenia.	O
There	O
is	O
scoliosis	O
of	O
the	O
thoracic	O
spine.	O
Vertebral	B-Vertebral_compression_fracture
body	O
heights	O
are	O
preserved	O
without	O
evidence	O
of	O
acute	O
fracture.	B-Vertebral_compression_fracture
No	O
suspicious	O
osseous	O
lesions	O
are	O
identified.	O
There	O
are	O
mild	O
multilevel	O
degenerative	O
disc	O
changes	O
characterized	O
by	O
loss	O
of	O
disc	O
height	O
and	O
endplate	O
sclerosis.	O
Lumbar	O
spine:	O
There	O
is	O
diffuse	O
osteopenia.	O
Dextroscoliosis	O
of	O
the	O
lumbar	O
spine	O
is	O
centered	O
at	O
L2-3.	O
There	O
is	O
grade	O
1	O
anterolisthesis	O
of	O
L4	O
on	O
L5.	O
There	O
is	O
a	O
new	O
L4	O
superior	O
endplate	O
compression	O
deformity	O
with	O
approximately	O
25%	O
height	O
loss.	O
No	O
suspicious	O
osseous	O
lesions	O
are	O
identified.	O
There	O
are	O
mild-to-moderate	O
multilevel	O
degenerative	O
disc	O
changes	O
throughout	O
the	O
lumbar	O
spine,	O
which	O
are	O
most	O
pronounced	O
at	O
the	O
L5-S1	O
level.	O
There	O
are	O
moderate	O
to	O
severe	O
degenerative	O
facet	O
changes,	O
which	O
are	O
most	O
pronounced	O
in	O
the	O
lower	O
lumbar	O
spine.	O
IMPRESSION:	O
1.	O
New	O
L4	O
superior	O
endplate	O
compression	O
deformity	O
with	O
approximately	O
25%	O
height	O
loss.	O
2.	O
No	O
acute	O
fracture	B-Vertebral_compression_fracture
in	O
the	O
thoracic	B-Vertebral_compression_fracture
spine.	B-Vertebral_compression_fracture
3.	O
bones	O
appear	O
diffusely	O
demineralized.	O
Brief	O
Hospital	O
Course:	O
Summary:	O
Mrs.	O
___	O
is	O
a	O
___	O
with	O
a	O
history	O
of	O
ulcerative	O
colitis	O
s/p	O
total	O
proctocolectomy	O
with	O
end	O
ileostomy,	O
multiple	O
small	O
bowel	O
obstructions,	O
and	O
aortic	O
stenosis	O
who	O
presented	O
with	O
light-headedness	O
and	O
___	O
bags	O
of	O
watery	O
ileostomy	O
output/day	O
after	O
recently	O
being	O
discharged	O
from	O
the	O
___	O
___.	O
She	O
was	O
also	O
found	O
to	O
have	O
elevated	O
AST/ALT	O
to	O
the	O
200's	O
and	O
elevated	O
alkaline	O
phosphatase	O
with	O
records	O
from	O
___	O
and	O
Women's	O
showing	O
positive	O
___	O
at	O
1:1280	O
and	O
positive	O
anti-smooth	O
muscle	O
antibodies,	O
concerning	O
for	O
autoimmune	O
hepatitis,	O
s/p	O
percutaneous	O
liver	O
biopsy	O
___.	O
Cosyntropin	O
stimulation	O
test	O
___	O
concerning	O
for	O
primary	O
adrenal	O
insufficiency,	O
patient	O
initiated	O
on	O
hydrocortisone.	O
Patient	O
was	O
also	O
noted	O
to	O
have	O
worsening	O
back	O
pain	O
prior	O
to	O
discharge,	O
found	O
to	O
have	O
L4	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture,	B-Vertebral_compression_fracture
managed	O
with	O
APAP/tramadol/lidocaine	O
patch/oxycodone.	O
Also	O
found	O
to	O
have	O
moderate	O
AS.	O
Acute	O
Problems	O
=============	O
#Light-headedness	O
#Increased	O
ileostomy	O
output	O
Recently	O
discharged	O
from	O
___,	O
where	O
she	O
had	O
positive	O
orthostatic	O
vitals	O
and	O
her	O
dizziness	O
had	O
improved	O
with	O
IV	O
fluids,	O
consistent	O
with	O
hypovolemia	O
in	O
the	O
setting	O
of	O
high	O
ostomy	O
output.	O
Stool	O
studies	O
were	O
negative	O
for	O
C.	O
Diff	O
and	O
stool	O
ova/parasites	O
were	O
pending	O
at	O
the	O
time	O
of	O
discharge.	O
CRP	O
was	O
0.9.	O
High	O
ostomy	O
output	O
likely	O
secondary	O
to	O
lack	O
of	O
colonic	O
water	O
absorption.	O
Her	O
home	O
Tramadol	O
for	O
back	O
pain	O
was	O
initially	O
held	O
given	O
concern	O
for	O
light-headedness.	O
She	O
was	O
given	O
bolus	O
IV	O
lactated	O
Ringer's	O
with	O
initial	O
improvement	O
in	O
light-headedness.	O
GI	O
was	O
consulted	O
for	O
assistance	O
with	O
her	O
ostomy	O
output	O
and	O
her	O
elevated	O
transaminases	O
and	O
alkaline	O
phosphatase	O
(as	O
below).	O
During	O
this	O
admission,	O
she	O
had	O
multiple	O
orthostatic	O
episodes	O
which	O
resolved	O
with	O
IVF.	O
Her	O
loperamide	O
and	O
diphynoxylate-atropine	O
were	O
increased,	O
with	O
appropriate	O
slowing	O
of	O
her	O
ileostomy	O
output	O
to	O
the	O
point	O
where	O
she	O
was	O
able	O
to	O
maintain	O
hydration	O
via	O
PO.	O
Given	O
concern	O
fro	O
persistent	O
symptomatic	O
orthostasis,	O
she	O
underwent	O
broad	O
workup	O
with	O
negative	O
HIV,	O
normal	O
SPEP	O
and	O
UPEP,	O
normal	O
B12.	O
She	O
was	O
found	O
to	O
have	O
adrenal	O
insufficiency	O
as	O
below.	O
[]	O
AI	O
treatment	O
as	O
below	O
[]	O
Continue	O
diphenoxylate-atropine	O
2.5mg/0.025mg	O
1	O
tab	O
TID	O
prn,	O
loperamide	O
2mg	O
tid	O
[]	O
Patient	O
counseled	O
to	O
maintain	O
adequate	O
po	O
hydration	O
[]	O
Please	O
follow-up	O
with	O
your	O
GI	O
doctor	O
Dr.	O
___	O
as	O
scheduled	O
#Adrenal	O
insufficiency:	O
Morning	O
cortisol	O
borderline	O
low	O
at	O
2.8	O
(5:50am)	O
and	O
8.3	O
(8:40am),	O
___	O
stim	O
test	O
with	O
increase	O
in	O
cortisol	O
from	O
4.9	O
to	O
16.8	O
peak	O
at	O
60min,	O
consistent	O
with	O
primary	O
adrenal	O
insufficiency.	O
ACTH	O
drawn	O
just	O
prior	O
to	O
Cosyntropin	O
administration	O
still	O
pending.	O
Her	O
adrenal	O
insufficiency	O
may	O
be	O
contributing	O
to	O
her	O
subjective	O
orthostatic	O
symptoms	O
of	O
lightheadedness.	O
[]	O
Please	O
continue	O
hydrocortisone	O
po,	O
10mg	O
at	O
10am	O
and	O
5mg	O
at	O
5pm	O
daily	O
(patient	O
understands	O
that	O
she	O
is	O
to	O
triple	O
her	O
hydrocortisone	O
iso	O
acute	O
illness,	O
she	O
was	O
also	O
provided	O
with	O
a	O
prescription	O
for	O
rescue	O
dexamethasone	O
IM)	O
[]	O
Patient	O
also	O
encouraged	O
to	O
obtain	O
medical	O
alert	O
bracelet	O
for	O
adrenal	O
insufficiency	O
in	O
case	O
found	O
down	O
[]	O
Endocrinology	O
follow-up.	O
She	O
already	O
is	O
supposed	O
to	O
be	O
seeing	O
an	O
endocrinologist	O
Dr.	O
___	O
at	O
___.	O
Patient	O
provided	O
with	O
phone	O
number	O
to	O
schedule	O
this	O
appointment	O
at	O
her	O
convenience	O
over	O
the	O
next	O
___.	O
[]	O
Sodium	O
chloride	O
tabs	O
were	O
held	O
given	O
that	O
patient	O
will	O
have	O
increased	O
Na	O
resorption	O
with	O
initiation	O
of	O
hydrocortisone	O
#Mixed	O
cholestatic/hepatocellular	O
liver	O
injury	O
#c/f	O
autoimmune	O
hepatitis	O
ALT	O
264,	O
AST	O
262,	O
Alk	O
Phos	O
229.	O
Hepatitis	O
A	O
IgM	O
negative.	O
Workup	O
at	O
___	O
notable	O
for	O
___	O
positive	O
(1:1280)	O
and	O
anti-smooth	O
muscle	O
Ab	O
positive.	O
Liver	O
U/S	O
was	O
normal	O
except	O
for	O
a	O
hepatic	O
cyst.	O
In	O
the	O
setting	O
of	O
liver	O
injury,	O
her	O
home	O
atorvastatin	O
was	O
held.	O
GI	O
was	O
consulted	O
and	O
recommended	O
MRCP,	O
which	O
showed	O
no	O
acute	O
biliary	O
or	O
hepatic	O
process.	O
Her	O
known	O
hepatic	O
cysts	O
and	O
nonobstructed	O
parastomal	O
hernia	O
were	O
noted.	O
Her	O
AST,	O
ALT,	O
and	O
alkaline	O
phosphatase	O
were	O
trended	O
daily	O
and	O
remained	O
elevated.	O
Hepatology	O
was	O
consulted,	O
and	O
recommended	O
a	O
percutaneous	O
liver	O
biopsy,	O
which	O
was	O
peformed	O
___,	O
results	O
pending	O
at	O
time	O
of	O
discharge.	O
[]	O
Outpatient	O
hepatology	O
follow-up	O
as	O
scheduled	O
[]	O
F/u	O
serum	O
immunoglobulin	O
levels,	O
liver	O
biopsy	O
results	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
#Lumbar	I-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture:	B-Vertebral_compression_fracture
New	O
___	O
back	O
pain	O
on	O
___,	O
found	O
to	O
have	O
L4	B-Vertebral_compression_fracture
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
on	O
spine	O
X	O
ray.	O
She	O
had	O
previously	O
had	O
an	O
X-ray	O
done	O
at	O
___	O
that	O
showed	O
demineralization	O
but	O
did	O
not	O
show	O
this	O
fracture.	O
While	O
not	O
on	O
steroids	O
recently,	O
she	O
does	O
have	O
osteoporosis	O
___	O
longstanding	O
steroid	O
use	O
in	O
the	O
past	O
for	O
UC.	O
-	O
Acetaminophen	O
650mg	O
TID,	O
Tramadol	O
50mg	O
QID,	O
Lidocaine	O
patch,	O
Oxycodone	O
5mg	O
q4h	O
prn	O
for	O
breakthrough	O
pain	O
-	O
Ensure	O
f/u	O
with	O
endocrinology	O
for	O
osteoporosis	O
management	O
as	O
outpatient	O
#Hyponatremia:	O
Initially	O
with	O
mild	O
hyponatremia	O
thought	O
to	O
be	O
hypovolemic	O
hyponatremia	O
iso	O
ostomy	O
losses	O
as	O
above.	O
Na	O
normalized	O
with	O
IVF.	O
Na	O
then	O
fell	O
to	O
130	O
on	O
___,	O
urine	O
Na<20.	O
Patient	O
was	O
given	O
an	O
additional	O
2L	O
LR	O
and	O
Na	O
improved	O
to	O
133	O
on	O
day	O
of	O
discharge.	O
Patient	O
was	O
continued	O
on	O
salt	O
tabs.	O
AI	O
treatment	O
as	O
above.	O
#Aortic	O
stenosis:	O
Ms.	O
___	O
had	O
been	O
seeing	O
Dr.	O
___	O
at	O
___	O
for	O
stable	O
aortic	O
stenosis,	O
and	O
was	O
undergoing	O
outpatient	O
workup.	O
TTE	O
___	O
showing	O
EF	O
66%,	O
concentric	O
LVH	O
with	O
LA	O
and	O
RA	O
dilatation.	O
Calcified	O
triscuspid	O
aortic	O
valve	O
with	O
mean	O
gradient	O
17.14	O
mmHg,	O
LVOT	O
velocity	O
0.9	O
m/s.	O
Mild	O
calcific	O
mitral	O
stenosis.	O
No	O
PFO	O
on	O
bubble	O
study.	O
This	O
admission,	O
she	O
underwent	O
repeat	O
TTE	O
(___)	O
to	O
assess	O
for	O
progression	O
of	O
aortic	O
stenosis,	O
showing:	O
aortic	O
valve	O
area	O
1.1cm^2,	O
valve	O
index	O
___,	O
mean	O
aortic	O
valve	O
gradient	O
21	O
mmHg,	O
peak	O
gradient	O
38	O
mmHg,	O
jet	O
0.1	O
(LEVF	O
normal).	O
[]	O
F/u	O
with	O
cardiologist	O
Dr.	O
___	O
as	O
an	O
outpatient,	O
consider	O
stress	O
test/TAVR	O
eval	O
if	O
symptomatic	O
Stable/Chronic	O
Issues:	O
======================	O
#Chronic	O
back	O
pain:	O
Radicular	O
back	O
pain	O
with	O
spinal	O
stenosis	O
worked	O
up	O
as	O
an	O
outpatient,	O
decided	O
against	O
spine	O
surgery.	O
Taking	O
Tramadol	O
at	O
home	O
for	O
pain,	O
which	O
was	O
held	O
due	O
to	O
concern	O
for	O
light-headedness,	O
subsequently	O
restarted	O
prior	O
to	O
discharge.	O
___	O
esophagus:	O
No	O
acute	O
issues	O
this	O
admission,	O
started	O
on	O
40	O
mg	O
pantoprazole	O
po	O
daily.	O
[]	O
Will	O
need	O
outpatient	O
upper	O
endoscopy	O
for	O
monitoring.	O
Follow	O
up	O
with	O
Dr.	O
___	O
as	O
above.	O
#Hypothyroidism:	O
Continued	O
home	O
synthroid	O
#Restless	O
Leg	O
Syndrome:	O
Continued	O
Mirapex	O
and	O
Gabapentin	O
#HLD:	O
Initially	O
held	O
atorvastatin	O
(restarted),	O
continued	O
aspirin	O
>30	O
minutes	O
spent	O
on	O
care/coordination	O
on	O
day	O
of	O
discharge	O
Transitional	O
Issues	O
===================	O
Follow-up:	O
[]	O
Hepatology	O
follow	O
up	O
as	O
scheduled	O
[]	O
GI	O
f/u	O
with	O
Dr	O
___	O
as	O
scheduled	O
[]	O
Please	O
schedule	O
cardiology	O
follow-up	O
with	O
patient's	O
existing	O
cardiologist	O
as	O
above	O
(office	O
has	O
been	O
called)	O
[]	O
Please	O
follow	O
up	O
with	O
endocrinology,	O
Dr.	O
___	O
at	O
___	O
___	O
(office	O
has	O
been	O
called)	O
[]	O
Please	O
ensure	O
that	O
patient	O
has	O
emergency	O
dexamethasone	O
prescription	O
and	O
medical	O
history	O
alert	O
bracelet	O
[]	O
Please	O
monitor	O
patient	O
for	O
HTN	O
and	O
volume	O
overload	O
s/p	O
initiation	O
of	O
steroids	O
[]	O
Please	O
evaluate	O
back	B-Vertebral_compression_fracture
pain	O
iso	O
compression	B-Vertebral_compression_fracture
fracture,	B-Vertebral_compression_fracture
tailor	O
pain	O
regimen	O
as	O
needed	O
Studies/Labs:	O
[]	O
Please	O
repeat	O
BMP	O
within	O
one	O
week	O
to	O
ensure	O
that	O
Na	O
is	O
stable	O
Procedures:	O
[]	O
F/u	O
with	O
Dr.	O
___	O
as	O
above	O
for	O
upper	O
endoscopy	O
for	O
monitoring	O
of	O
___	O
esophagus	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Gabapentin	O
300	O
mg	O
PO	O
TID	O
2.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
3.	O
Mirapex	O
ER	O
(pramipexole)	O
0.5	O
mg	O
oral	O
TID	O
4.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
5.	O
Albuterol	O
Inhaler	O
1	O
PUFF	O
IH	O
Q6H:PRN	O
wheezing	O
6.	O
Diphenoxylate-Atropine	O
1	O
TAB	O
PO	O
QAM	O
7.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
LOPERamide	O
2	O
mg	O
PO	O
QID:PRN	O
diarrhea	O
10.	O
sodium	O
chloride	O
1	O
gram	O
oral	O
Daily	O
11.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
DAILY	O
12.	O
Vitamin	O
D	O
800	O
UNIT	O
PO	O
DAILY	O
13.	O
melatonin	O
5	O
mg	O
oral	O
QPM:PRN	O
14.	O
TraMADol	O
50	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
TID	O
RX	O
*acetaminophen	O
[8	O
Hour	O
Pain	O
Reliever]	O
650	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*21	O
Tablet	O
Refills:*0	O
2.	O
Dexamethasone	O
4	O
mg	O
IM	O
ASDIR	O
adrenal	O
crisis	O
Inject	O
into	O
thigh	O
if	O
ill	O
and	O
unable	O
to	O
take	O
oral	O
steroids	O
RX	O
*dexamethasone	O
sodium	O
phosphate	O
[ReadySharp	O
dexamethasone]	O
10	O
mg/mL	O
0.4	O
mL	O
IM	O
PRN	O
Disp	O
#*1	O
Kit	O
Refills:*5	O
3.	O
Hydrocortisone	O
10	O
mg	O
PO	O
QAM	O
Adrenal	O
insufficiency	O
RX	O
*hydrocortisone	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
qAM	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
4.	O
Hydrocortisone	O
5	O
mg	O
PO	O
QPM	O
RX	O
*hydrocortisone	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
qPM	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
5.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
DAILY	O
RX	O
*lidocaine	O
[Lidoderm]	O
5	O
%	O
Place	O
over	O
pain	O
on	O
back	O
once	O
a	O
day	O
Disp	O
#*15	O
Patch	O
Refills:*0	O
6.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
BREAKTHROUGH	O
PAIN	O
RX	O
*oxycodone	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
q4	O
Disp	O
#*20	O
Tablet	O
Refills:*0	O
7.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
Please	O
continue	O
to	O
take	O
until	O
advised	O
otherwise	O
during	O
followup	O
with	O
Dr.	O
___.	O
RX	O
*pantoprazole	O
40	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
8.	O
Diphenoxylate-Atropine	O
1	O
TAB	O
PO	O
TID:PRN	O
high	O
ileostomy	O
output	O
Please	O
take	O
up	O
to	O
3	O
times/day	O
depending	O
on	O
your	O
ileostomy	O
output.	O
RX	O
*diphenoxylate-atropine	O
[Lomotil]	O
2.5	O
mg-0.025	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*21	O
Tablet	O
Refills:*0	O
9.	O
LOPERamide	O
2	O
mg	O
PO	O
TID	O
diarrhea	O
RX	O
*loperamide	O
2	O
mg	O
1	O
capsule	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*21	O
Capsule	O
Refills:*0	O
10.	O
Albuterol	O
Inhaler	O
1	O
PUFF	O
IH	O
Q6H:PRN	O
wheezing	O
11.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
12.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
13.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
DAILY	O
14.	O
Gabapentin	O
300	O
mg	O
PO	O
TID	O
15.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
16.	O
melatonin	O
5	O
mg	O
oral	O
QPM:PRN	O
17.	O
Mirapex	O
ER	O
(pramipexole)	O
0.5	O
mg	O
oral	O
TID	O
18.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
19.	O
sodium	O
chloride	O
1	O
gram	O
oral	O
Daily	O
20.	O
TraMADol	O
50	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
21.	O
Vitamin	O
D	O
800	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnoses	O
=================	O
#High	O
ileostomy	O
output	O
#Hypovolemia	O
#Mixed	O
hepatocellular	O
and	O
cholestatic	O
liver	O
injury	O
#Aortic	O
stenosis	O
#Adrenal	O
insufficiency	O
#Hyponatremia	O
Secondary	O
Diagnoses	O
===================	O
#Ulcerative	O
colitis	O
s/p	O
proctocolectomy	O
with	O
end	O
ileostomy	O
#Hypothyroidism	O
___	O
esophagus	O
Discharge	O
Condition:	O
AfVSS	O
Ambulating	B-Mobile_with_aid
independently	B-Mobile_with_aid
with	B-Mobile_with_aid
cane	B-Mobile_with_aid
Mental	B-Delirium
status	B-Delirium
clear,	B-Delirium
coherent,	B-Delirium
AOx3	B-Delirium
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
-You	O
were	O
hospitalized	O
due	O
to	O
increased	O
output	O
from	O
your	O
ileostomy	O
and	O
dizziness.	O
What	O
happened	O
during	O
your	O
hospitalization?	O
-Your	O
stool	O
was	O
tested	O
and	O
cultured	O
to	O
rule	O
out	O
several	O
different	O
infections,	O
including	O
C.	O
difficile	O
and	O
parasites,	O
all	O
of	O
which	O
were	O
negative.	O
-You	O
were	O
given	O
intravenous	O
fluids	O
to	O
rehydrate	O
you	O
in	O
the	O
setting	O
of	O
your	O
increased	O
ileostomy	O
losses.	O
-You	O
were	O
found	O
to	O
have	O
elevated	O
liver	O
enzyme	O
tests	O
and	O
underwent	O
testing	O
to	O
examine	O
the	O
cause.	O
A	O
special	O
MRI	O
of	O
your	O
liver	O
and	O
bile	O
ducts	O
called	O
an	O
MRCP	O
was	O
done	O
and	O
revealed	O
no	O
concerning	O
changes	O
in	O
your	O
liver	O
or	O
bile	O
duct.	O
It	O
did	O
show	O
known	O
liver	O
cysts	O
and	O
a	O
hernia	O
around	O
your	O
ileostomy	O
site.	O
However,	O
your	O
liver	O
enzymes	O
remained	O
elevated,	O
and	O
records	O
from	O
the	O
___	O
were	O
obtained	O
that	O
showed	O
results	O
consistent	O
with	O
an	O
autoimmune	O
liver	O
disease,	O
so	O
you	O
were	O
also	O
seen	O
by	O
the	O
liver	O
specialist	O
doctors	O
(___).	O
You	O
underwent	O
percutaneous	O
biopsy	O
of	O
the	O
liver	O
by	O
the	O
Interventional	O
Radiology	O
team	O
to	O
assist	O
in	O
diagnosing	O
the	O
cause	O
of	O
your	O
elevated	O
liver	O
enzymes.	O
-The	O
gastroenterology	O
team	O
led	O
by	O
Dr.	O
___	O
was	O
consulted	O
to	O
evaluate	O
your	O
ileostomy	O
output	O
and	O
your	O
elevated	O
liver	O
enzyme	O
tests.	O
-Your	O
home	O
medication	O
Immodium	O
were	O
adjusted,	O
with	O
reduction	O
in	O
your	O
ileostomy	O
output.	O
The	O
Lomotil	O
dosing	O
was	O
adjusted	O
to	O
1	O
tablet	O
3	O
times/day	O
and	O
the	O
Immodium	O
dose	O
was	O
adjusted	O
to	O
2mg	O
3	O
times/day.	O
-You	O
underwent	O
an	O
echocardiogram	O
(ultrasound	O
of	O
the	O
heart)	O
to	O
assess	O
your	O
aortic	O
stenosis,	O
which	O
showed	O
moderate	O
progression	O
of	O
your	O
aortic	O
stenosis.	O
-You	O
underwent	O
multiple	O
blood	O
tests	O
to	O
determine	O
the	O
cause	O
of	O
your	O
dizziness.	O
These	O
showed	O
insufficient	O
production	O
of	O
a	O
hormone	O
called	O
cortisol	O
by	O
your	O
adrenal	O
glands,	O
so	O
you	O
were	O
started	O
on	O
hydrocortisone	O
replacement.	O
-	O
You	O
developed	O
severe	O
back	O
pain	O
and	O
were	O
found	O
to	O
have	O
a	O
compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
in	O
your	O
lumbar	B-Vertebral_compression_fracture
spine	B-Vertebral_compression_fracture
(level	O
L4).	O
You	O
were	O
given	O
medications	O
for	O
pain.	O
What	O
should	O
you	O
do	O
when	O
you	O
leave	O
the	O
hospital?	O
-	O
Continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
-	O
Follow-up	O
with	O
your	O
specialty	O
health	O
care	O
appointments	O
as	O
listed	O
below	O
-	O
You	O
were	O
started	O
on	O
hydrocortisone	O
upon	O
discharge.	O
Please	O
continue	O
to	O
take	O
this	O
medication	O
as	O
prescribed	O
(10	O
mg	O
in	O
the	O
morning	O
at	O
10AM	O
and	O
5	O
mg	O
at	O
5PM)	O
until	O
advised	O
at	O
either	O
your	O
hepatology	O
or	O
your	O
endocrinology	O
appointment.	O
In	O
the	O
interim,	O
if	O
you	O
develop	O
an	O
illness	O
such	O
as	O
the	O
cold	O
or	O
flu,	O
please	O
take	O
a	O
triple	O
dose	O
of	O
hydrocortisone,	O
30	O
mg	O
in	O
the	O
morning	O
and	O
15	O
in	O
the	O
evening,	O
for	O
3	O
days.	O
If	O
you	O
continue	O
to	O
feel	O
unwell	O
or	O
if	O
you	O
are	O
nauseous	O
and	O
unable	O
to	O
take	O
oral	O
medications,	O
please	O
self-administer	O
intramuscular	O
injection	O
of	O
dexamethasone	O
into	O
the	O
thigh	O
and	O
come	O
to	O
the	O
emergency	O
room.	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you!	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

